CIBC Bancorp USA’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Buy
10,223
+1,155
+13% +$136K ﹤0.01% 1072
2026
Q2
$955K Sell
9,068
-1,938
-18% -$235K ﹤0.01% 1114
2026
Q1
$1.8M Buy
+11,006
New +$1.69M ﹤0.01% 927

Other funds holding INSM

CIBC Bancorp USA's INSM Position: Q3 2026 in Review

CIBC Bancorp USA increased its Insmed (INSM) stake by 13% in Q3 2026, buying an estimated $136K and bringing the position to 10,223 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

CIBC Bancorp USA first reported a position in INSM in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.8M in Q1 2026. 704 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • CIBC Bancorp USA held 10,223 shares of Insmed worth $1.17M as of Q3 2026.
  • CIBC Bancorp USA bought 1,155 Insmed shares in Q3 2026, an estimated $136K.
  • Insmed made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1072 holding.
  • CIBC Bancorp USA first reported a position in Insmed in Q1 2026 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Insmed position peaked at $1.8M in Q1 2026.
  • 704 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.